Table 2:

Comparison of baseline characteristics among the 3 groups

CE (n = 110)LAA (n = 43)Undetermined Etiology (n = 41)PaPb
Age (yr)74 (66–80)67 (56–79)63 (59–79).016.016
Male sex (No.) (%)52 (47.3%)32 (74.4%)28 (68.3%).003.002
Baseline NIHSS score14 (10–18)10 (5–14)14 (9–18).002.001
Systolic BP (mm Hg)150 (133–168)154 (138–164)144 (129–155).172.450
Diastolic BP (mm Hg)79 (71–94)80 (72–93)78 (68–89).370.955
Onset-to-imaging time (min)154 (92–225)163 (112–230)197 (134–262).128.540
Prior antiplatelet use (No.) (%)19 (17.3%)6 (14.0%)8 (19.5%).790.618
Risk factors
    Smoking (No.) (%)28 (25.5%)21 (48.8%)16 (39.0%).016.005
    Hypertension (No.) (%)73 (66.4%)29 (67.4%)23 (56.1%).451.899
    Diabetes mellitus (No.) (%)20 (18.2%)11 (25.6%)5 (12.2%).285.306
    Hyperlipidemia (No.) (%)41 (37.3%)15 (34.9%)17 (41.5%).818.783
    History of stroke/TIA (No.) (%)19 (17.3%)9 (20.9%)4 (9.8%).365.599
    Atrial fibrillation (No.) (%)98 (89.1%)0 (0.0%)11 (26.8%)<.001<.001
    MSC sign (No.) (%)58 (52.7%)4 (9.3%)12 (29.3%)<.001<.001
  • Note:—BP indicates blood pressure.

  • a Data are expressed as median (Q1–Q3) for continuous variables among the 3 groups.

  • b Data are expressed as median (Q1–Q3) for continuous variables between CE and LAA.